Pujol-Pujol, M.; Rivero-Martínez, M.; Puente, J.; Vidal, N.; Calvo, M.; Riaza, C.; Álvarez-Nadal, M.; Rodríguez-Moreno, A.; Sánchez-Fructuoso, A.I.; García-Carro, C.
Abiraterone-Associated Renal Damage in Patients with Advanced Prostate Cancer as a Risk Factor for Mortality and Chronic Kidney Disease. J. Clin. Med. 2025, 14, 7559.
https://doi.org/10.3390/jcm14217559
AMA Style
Pujol-Pujol M, Rivero-Martínez M, Puente J, Vidal N, Calvo M, Riaza C, Álvarez-Nadal M, Rodríguez-Moreno A, Sánchez-Fructuoso AI, García-Carro C.
Abiraterone-Associated Renal Damage in Patients with Advanced Prostate Cancer as a Risk Factor for Mortality and Chronic Kidney Disease. Journal of Clinical Medicine. 2025; 14(21):7559.
https://doi.org/10.3390/jcm14217559
Chicago/Turabian Style
Pujol-Pujol, Marina, Marta Rivero-Martínez, Javier Puente, Natalia Vidal, Marta Calvo, Cristina Riaza, Marta Álvarez-Nadal, Antolina Rodríguez-Moreno, Ana I. Sánchez-Fructuoso, and Clara García-Carro.
2025. "Abiraterone-Associated Renal Damage in Patients with Advanced Prostate Cancer as a Risk Factor for Mortality and Chronic Kidney Disease" Journal of Clinical Medicine 14, no. 21: 7559.
https://doi.org/10.3390/jcm14217559
APA Style
Pujol-Pujol, M., Rivero-Martínez, M., Puente, J., Vidal, N., Calvo, M., Riaza, C., Álvarez-Nadal, M., Rodríguez-Moreno, A., Sánchez-Fructuoso, A. I., & García-Carro, C.
(2025). Abiraterone-Associated Renal Damage in Patients with Advanced Prostate Cancer as a Risk Factor for Mortality and Chronic Kidney Disease. Journal of Clinical Medicine, 14(21), 7559.
https://doi.org/10.3390/jcm14217559
